BusinessEaston Pharmaceuticals Announces BAYER Agreement UpdateBy Nasdaq OMXApr 16, 2018, 12:01 PM UTC
BusinessEaston Pharmaceuticals Announces Development of a Blockchain and Cryptocurrency InitiativeBy Nasdaq OMXMar 21, 2018, 12:01 PM UTC
BusinessEaston Pharmaceuticals Announces the Appointment of Mr. Luigi Gentile as Director and Officer to the CompanyBy Nasdaq OMXJan 10, 2018, 2:04 PM UTC
BusinessEaston Pharmaceuticals & Partner BMV Medica Announce Delivery and Launch of AmnioSense (AL-Sense) in Mexico; Delivery Date for Purchase Order From Windsor Pharmaceuticals for Central AmericaBy Nasdaq OMXDec 6, 2017, 1:00 PM UTC
